A new partnership will reportedly open up more than 200 clinical cancer trials to local patients.
This item is available in full to subscribers.
We have recently launched a new and improved website. To continue reading, you will need to either log into your subscriber account, or purchase a new subscription.
If you are a digital subscriber with an active subscription, then you already have an account here. Just reset your password if you've not yet logged in to your account on this new site.
If you are a current print subscriber, you can set up a free website account by clicking here.
Otherwise, click here to view your options for subscribing.
If you're a print subscriber, but do not yet have an online account, click here to create one.
Click here to see your options for becoming a subscriber.
The clinical research and education association between Lexington Medical Cancer Center and MUSC Hollings Cancer Center in Charleston is the second high-profile partnership Lexington Medical Center and MUSC Health have unveiled this month.
The two providers previously unveiled a collaboration between them, Alliance for a Healthier SC, the S.C. Hospital Association and the state Department of Health and Environmental Control to conduct a Community Health Needs Assessment to identify the health care priorities of Midlands residents.
Lexington Medical trumpeted the potential benefits of the cancer partnership in a press release.
“This partnership will provide Lexington Medical Center patients access to MUSC’s National Cancer Institute-designated clinical trials and continue to ensure they receive high quality and comprehensive cancer services,” the release states.
"Through this affiliation, Lexington Medical Cancer Center will work collaboratively with MUSC to advance the expertise of clinical staff and offer the latest in cancer treatment research. Specifically, the affiliation with MUSC Hollings Cancer Center will allow Lexington Medical Center’s patients access to more than 200 clinical trials, providing patients in the Midlands a wide range of the most promising cancer treatments currently available in the nation.”
According to the release, the Hollings Cancer Center, one of 71 National Cancer Institute-designated cancer centers, has more than 120 scientists working to find better ways to prevent, detect, diagnose and treat cancer.
“As the Midlands’ only hospital providing comprehensive cancer care, we are excited about the benefits our affiliation with MUSC Hollings Cancer Center brings to our patients,” Dr. Quillin Davis, medical director of cancer services at Lexington Medical Center, is quoted. “Having access to their National Cancer Institute-designated clinical trials and research expertise will allow our patients to receive the latest, most innovative treatment while staying here in their community.”
“MUSC Hollings Cancer Center is committed to improving the care of cancer patients across our state,” David Zaas, MUSC Health Charleston Division CEO, is quoted. “We are excited to partner with Lexington Medical Center to help ensure patients can access innovative clinical research trials and new approaches to care, including state of the art therapies closer to home.”
No comments on this item
Please log in to comment by clicking here
Other items that may interest you